Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of imatinib for plexiform neurofibroma in neurofibromatosis type 1
2009-016922-15Phase 2Active
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in plexiform neurofibroma (PN) and neurofibromatosis type 1 (NF1), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Objective response rate of imatinib in plexiform neurofibromas and Safety and tolerability of imatinib. Started Nov 2009; status: active.
02
Drugs
03
Conditions
plexiform neurofibroma (PN)neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on 2009-016922-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016922-15.